Japan · Health Care startup
Japan · K Pharma
K-Pharma creates pharmaceuticals by utilizing early-stage neuro regenerative medicine and iPS drug discovery.
Funding reportedLast round: Undisclosed round
What company datasets say K Pharma raised
Funding, as reported
Reported in all1.6Bin the source's currency
Rounds1
Last roundUndisclosed round
Last round dateMay 2022
Investors listed5
Founders and team
From K Pharma's own website: 2 on the team.
- Masato Matsumoto常務取締役cfo
- Masaya Nakamura取締役cto
On a portfolio page
Investors who name them
Each firm lists K Pharma on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Health Care in Japan
Startups like it
Is this your company?
Add your raise, your deck and your story, and put K Pharma in front of investors. Or tell us what we have wrong.